The Valley Desk

NCT00350948 · Interventional trial

Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer

Overall registry status Terminated

Phase 3

Conditions Ovarian Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov